Rituximab, fludarabine, mitoxantrone, and dexamethasone (R-FND) for patients with relapsed indolent B-cell lymphoma (RIL). Background: Anatomic imaging by contrast-enhanced computed tomography (CECT), ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results